Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.
作者:
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗体, 肿瘤(Antibodies, Neoplasm);抗肿瘤药(Antineoplastic Agents);抗药性, 肿瘤(Drug Resistance, Neoplasm);人类(Humans);白血病, 大颗粒淋巴细胞(Leukemia, Large Granular Lymphocytic);男(雄)性(Male);中年人(Middle Aged);缓解诱导(Remission Induction);挽救疗法(Salvage Therapy);治疗结果(Treatment Outcome)
DOI
10.1016/j.leukres.2010.01.019
PMID
20211489
发布时间
2017-11-16
- 浏览13

Leukemia research
e197-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文